Am­gen is shak­ing up R&D (again), chop­ping 200 as Genen­tech tar­gets 130 lay­offs

Two biotech gi­ants — Am­gen and Genen­tech — are lay­ing off a com­bined 330 peo­ple at Cal­i­for­nia fa­cil­i­ties, both cit­ing “or­ga­ni­za­tion­al changes” as the pri­ma­ry rea­son for the cuts.

Am­gen is shak­ing up its R&D de­part­ment, elim­i­nat­ing 200 po­si­tions at its Thou­sand Oaks, CA and South San Fran­cis­co fa­cil­i­ties by the end of this year, STAT re­port­ed Sat­ur­day. An Am­gen spokesper­son tells me the com­pa­ny is mak­ing or­ga­ni­za­tion­al changes across the globe in re­gards to its R&D de­part­ments. This round of lay­offs, how­ev­er, most­ly im­pacts fa­cil­i­ties in Cal­i­for­nia.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.


Alexandria Real Estate Equities

Cambridge, MA, USA